Clinical experience with daptomycin in Europe: the first 2.5 years

OBJECTIVES: To describe the patient populations and infections being treated with daptomycin, as well as the efficacy and safety outcomes. PATIENTS AND METHODS: Data from the European Cubicin Outcomes Registry and Experience (EU-CORE(SM)), retrospectively collected at 118 institutions between Januar...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzalez-Ruiz, Armando, Beiras-Fernandez, Andres, Lehmkuhl, Hans, Seaton, R. Andrew, Loeffler, Juergen, Chaves, Ricardo L.
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058564/
https://www.ncbi.nlm.nih.gov/pubmed/21393205
http://dx.doi.org/10.1093/jac/dkq528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058564/
https://www.ncbi.nlm.nih.gov/pubmed/21393205
http://dx.doi.org/10.1093/jac/dkq528

Ejemplares similares